BCR /abl QUANTITATIVE, PCR

BCR /abl QUANTITATIVE, PCR


Sample TypeEDTA
Pre Test InformationNo specific preparation required
Report DeliveryNA
Home CollectionAvailable

The quantitative BCR-ABL RNA assay is intended to monitor the level of minimal residual disease in TKI-treated Philadelphia chromosome positive leukemias (CML or ALL). High or rising BCR-ABL RNA levels have been shown to increase the risk of leukemic relapse and drug-resistance mutations during TKI therapy.